Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$17.99 USD
-3.97 (-18.08%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.99 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: AMC |
9/2024 | $0.02 | 42.86% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of $0.05 per share, beating the Zacks Consensus Estimate of $-0.01 per share. This reflects a positive earnings surprise of 600.00%. Look out for MYGN's next earnings release on November 07, 2024. For the next earning release, we expect the company to report earnings of $0.02 per share, reflecting a year-over-year increase of 166.67%.
Earnings History
Price & Consensus
Zacks News for MYGN
Myriad Genetics (MYGN) Earnings Expected to Grow: Should You Buy?
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services